SCHEMBL19082141

SCHEMBL19082141

c1ccc(-c2ccc(-c3c4ccccc4c(-c4ccc5sc6ccc7sc8c9ccccc9ccc8c7c6c5c4)c4ccccc34)cc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 5/20 0.44
CYP1B1 Q16678 5/20 0.44
CYP1A2 P05177 3/20 0.38
LIMK1 P53667 2/20 0.38
F9 P00740 2/20 0.35
PIM3 Q86V86 2/20 0.34
PIM1 P11309 1/20 0.34
PIM2 Q9P1W9 1/20 0.34
ESR1 P03372 3/20 0.33
ESR2 Q92731 3/20 0.33
KDM4E B2RXH2 1/20 0.33
NPC1 O15118 1/20 0.33
MAPT P10636 1/20 0.33
RAB9A P51151 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
CDK4 P11802 1/20 0.33
CCND1 P24385 1/20 0.33
NQO1 P15559 1/20 0.33
NQO2 P16083 1/20 0.33
CHEK1 O14757 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19082088 0.99 CYP1A1 (0.45) CYP1A1CYP1B1CYP1A2LIMK1F9
SCHEMBL19082212 0.97 CYP1A1 (0.44) CYP1A1CYP1B1CYP1A2LIMK1F9
SCHEMBL19082340 0.95 CYP1A1 (0.42) CYP1A1CYP1B1CYP1A2LIMK1F9
SCHEMBL19082219 0.95 CYP1A1 (0.45) CYP1A1CYP1B1CYP1A2LIMK1F9
SCHEMBL19082288 0.92 CYP1A1 (0.36) CYP1A1CYP1B1CYP1A2LIMK1F9
SCHEMBL19082138 0.92 CYP1A1 (0.38) CYP1A1CYP1B1CYP1A2LIMK1F9
SCHEMBL19082139 0.92 CYP1A1 (0.44) CYP1A1CYP1B1CYP1A2LIMK1F9
SCHEMBL19082095 0.91 CYP1A1 (0.45) CYP1A1CYP1B1CYP1A2LIMK1F9
SCHEMBL19082086 0.91 CYP1A1 (0.39) CYP1A1CYP1B1CYP1A2LIMK1F9
SCHEMBL19082089 0.91 CYP1A1 (0.45) CYP1A1CYP1B1CYP1A2LIMK1F9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885CYP1A2 659/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885CYP1A2 659/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.